Webber Lin

We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!

对于“通信行程卡”服务正式下线，我唯一的感觉仅仅是省去了我向他人展示我前14天到过的所有地市信息，但我更精细的活动轨迹数据仍时时产生并可以被人查。